Labcorp Business Update

March 23, 2021

Labcorp business update

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 23, 2021-- Labcorp (NYSE: LH), a leading life sciences company, today issued the following statement: Labcorp continues to make progress executing our strategy and capitalizing on the power of our diagnostic and drug development businesses.

Dr. Marcia Eisenberg, Chief Scientific Officer of Labcorp Diagnostics, Named a Healthcare Businesswoman's Association Luminary

March 9, 2021

PathAI and Labcorp broaden strategic collaboration to accelerate use of AI-powered pathology

BOSTON and BURLINGTON, N.C. – March 8, 2021 – PathAI, a global provider of artificial intelligence-powered (AI-powered) technology for use in pathology research, and Labcorp (NYSE: LH), a leading global life sciences company, today announced the broadening of their strategic partnership in the field of AI-powered pathology. The collaboration builds on Labcorp’s past investment in PathAI and the companies’ collaboration on a series of projects, including the deployment of PathAI algorithms in clinical trials managed by Labcorp Drug Development.

PathAI and Labcorp Broaden Strategic Collaboration to Accelerate Use of AI-Powered Pathology

Labcorp Named to Fast Company's List of The World's Most Innovative Companies For 2021